FTC Settles Case with Maker of Derma Tend Wart Removal Product for False Solace Claims

By on December 23, 2014

The Federal Trade Commission (FTC) announced that it settlement of a complaint filed against Solace International for allegedly using deceptive advertising to market its Derma Tend skin product.

Specifically, the FTC accused Solace of making unfounded claims that Derma Tend, based on clinical proof, permanently removed moles, skin tags and warts. Solace sells Derma Tend and an emery board for $39.95 with instructions to file down the wart or skin tag and then apply Derma Tend to the area.

“These companies made outrageous claims that their products could provide a range of benefits – from removing warts to decreasing the appearance of cellulite to providing substantial weight loss,” said Jessica Rich, Director of the Bureau of Consumer Protection.  “The common thread for all of these claims was the fundamental lack of scientific evidence. Consumers deserve better.”

If you would like additional information about the FTC’s settlement with Solace or other news, please click the green button below and fill out the form.